Tolazoline (hydrochloride)

Tolazoline hydrochloride (Imidaline hydrochloride) is an α-adrenergic receptor antagonist. Tolazoline hydrochloride inhibits Noradrenaline (HY-13715) -induced cell contraction, modulates vascular resistance, increases arterial pressure, and reverses bradycardia and tachypnea. Tolazoline hydrochloride can be used to study erectile dysfunction, α2-adrenergic receptor agonist-related poisoning, and skin vascular disease research[1][2][3][4][5][6][7].

Product Specifications

CAS Number

[59-97-2]

Product Name Alternative

Imidaline (hydrochloride) ; NSC35110 (hydrochloride)

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Adrenergic Receptor

Type

Natural Products

Related Pathways

GPCR/G Protein; Neuronal Signaling

Field of Research

Endocrinology; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/Tolazoline-hydrochloride.html

Purity

99.93

Solubility

DMSO : 33.33 mg/mL (ultrasonic) |H2O : ≥ 50 mg/mL

Smiles

[H]Cl.C1(CC2=CC=CC=C2)=NCCN1

Molecular Formula

C10H13ClN2

Molecular Weight

196.68

Precautions

H302, H315, H319, H335

References & Citations

[1]Megens AA, et al. Further validation of in vivo and in vitro pharmacological procedures for assessing the alpha 2/alpha 1-selectivity of test compounds: (1) . Alpha-adrenoceptor antagonists. Eur J Pharmacol. 1986 Sep 23;129 (1-2) :49-55.|[2]Schwartz DD, et al. Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheep. J Vet Pharmacol Ther. 1998 Oct;21 (5) :342-7.|[3]Costa P, et al. Adrenergic receptors on smooth muscle cells isolated from human penile corpus cavernosum. J Urol. 1993 Sep;150 (3) :859-63. |[4]Rogers RA, et al. Pharmacologic modulation of the cutaneous vasculature in the isolated perfused porcine skin flap. J Pharm Sci. 1994 Dec;83 (12) :1682-9.|[5]Lei L, et al. Activation of L-type calcium channel by tolazoline derivatives: role of isothiocyanate moiety. J Cardiovasc Pharmacol. 1998 May;31 (5) :721-33.|[6]BENFEY BG, et al. VASOCONSTRICTOR ACTION OF TOLAZOLINE. Br J Pharmacol Chemother. 1964 Feb;22 (1) :66-71.|[7]Hsu WH, et al. Effects of tolazoline and yohimbine on xylazine-induced central nervous system depression, bradycardia, and tachypnea in sheep. J Am Vet Med Assoc. 1987 Feb 15;190 (4) :423-6.